JYNARQUE
tolvaptan
- Strength
- 30 mg/1
- Form
- Tablet
- Class
- Vasopressin V2 Receptor Antagonist
Otsuka America Pharmaceutical, Inc.
Tolvaptan
Listed by Endo USA, Inc.
- Strength
- 15 mg/1
- Form
- Tablet
- Route
- Oral
- Class
- Vasopressin V2 Receptor Antagonist
What it contains
- Tolvaptan 15 mg/1
FDA record
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Vasopressin V2 Receptor Antagonist |
| Approval route | ANDA — approved generic |
| NDC code | 49884-768 |
| FDA application | ANDA206119 |
| Package sizes listed | 1 |
| Marketed since | March 2022 |
Other products containing Tolvaptan
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
JYNARQUE
tolvaptan
- Strength
- 15 mg/1
- Form
- Tablet
- Class
- Vasopressin V2 Receptor Antagonist
Otsuka America Pharmaceutical, Inc.
SAMSCA
tolvaptan
- Strength
- 15 mg/1
- Form
- Tablet
- Class
- Vasopressin V2 Receptor Antagonist
Otsuka America Pharmaceutical, Inc.
SAMSCA
tolvaptan
- Strength
- 30 mg/1
- Form
- Tablet
- Class
- Vasopressin V2 Receptor Antagonist
Otsuka America Pharmaceutical, Inc.
TOLVAPTAN
- Strength
- 30 mg/1
- Form
- Tablet
- Class
- Vasopressin V2 Receptor Antagonist
Novadoz Pharmaceuticals LLC
Tolvaptan
- Strength
- 30 mg/1
- Form
- Tablet
- Class
- Vasopressin V2 Receptor Antagonist
Camber Pharmaceuticals, Inc.
Tolvaptan
- Strength
- 15 mg/1
- Form
- Tablet
- Class
- Vasopressin V2 Receptor Antagonist
Ascend Laboratories, LLC
Tolvaptan
- Strength
- 60 mg/1
- Form
- Tablet
- Class
- Vasopressin V2 Receptor Antagonist
Ascend Laboratories, LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.